SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Opto Circuits soars on getting board’s approval for fund raising plans

07 May 2014 Evaluate

Opto Circuits (India) is currently trading at Rs. 32.85, up by 1.20 points or 3.79% from its previous closing of Rs. 31.65 on the BSE.

The scrip opened at Rs. 32.60 and has touched a high and low of Rs. 33.65 and Rs. 32.50 respectively. So far 522311 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 60.30 on 07-May-2013 and a 52 week low of Rs. 17.80 on 25-Jun-2013.

Last one week high and low of the scrip stood at Rs. 35.40 and Rs. 31.20 respectively. The current market cap of the company is Rs. 796.02 crore.

The promoters holding in the company stood at 28.22 % while Institutions and Non-Institutions held 30.82 % and 40.96 % respectively.

Opto Circuits (India) has received an approval to raise funds for the company and/or for its Indian/Overseas Subsidiaries up to an aggregate amount not exceeding $250 million. The board of director at its meeting held on May 06, 2014 has approved for the same.

The company will raise funds by way of issue of securities, including Global Depositary Receipts (GDRs) and or American Depository Receipts (ADRs) convertible into equity shares, or any instrument or securities representing convertible securities such as convertible debentures, bonds or warrants etc., convertible into equity shares, in one or more tranches, in Indian or Foreign Market(s) as applicable, whether optionally or otherwise or any combination thereof.

Opto Circuits India is a multinational medical device company headquartered out of Bengaluru, India. The company designs, develop, manufacture, market and distribute a range of medical products that are used by healthcare establishments in more than 150 countries.

Opto Circuits (I) Share Price

1.78 0.00 (0.00%)
23-May-2022 18:01 View Price Chart
Peers
Company Name CMP
Lenskart Solutions 534.85
Poly Medicure 1468.25
Laxmi Denta 195.10
Nureca Ltd. 263.80
Hemant Surgical Inds 297.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×